The largest database of trusted experimental protocols

10 protocols using anti cd34 pe cy7

1

Flow Cytometric Characterization of ASC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry analysis, cells were washed in PBS and subjected to immunofluorescence (IF) staining with anti-CD34-PE-Cy7 (BD Pharmingen, #556626), a rat monoclonal anti-human DLK1/Pref1 (AdipoGen, #AG-25A-0091) along with anti-rat-APC (BD Pharmingen, #5510109), anti-CD31-FITC (BD Pharmingen, #555445), anti-CD45-APC-Cy7 (BD Pharmingen, #561863) and anti-DPP4/CD26 (Biolegend, #302715). Cells were measured using a FACS Canto II (BD Bioscience), and data were analysed using FlowJo 10.5.2 software. For ex vivo analysis of ASC, flow cytometric sorting of freshly isolated SVFs was performed. Therefore, cells were subjected to IF staining with following antibodies: anti-CD34-PE-Cy7, a rat monoclonal anti-human DLK1/Pref1 along with anti-rat-APC, and anti-DPP4/CD26, and sorted using a FACS Aria (BD Bioscience). For cell count experiments, events recorded during 90 s were assessed, and separate biological triplicates were measured.
+ Open protocol
+ Expand
2

Isolation of Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Umbilical cord blood was collected in several hospitals using Stemcare/CB collect blood bag system (Fresenius Kabi Norge AS) containing citrate phosphate dextrose (CPD) as an anticoagulant. Approval for collection was obtained from the Medical Ethical Committee of the Erasmus University Medical Centre (MEC-2009–410) and written informed consent from the mother was obtained prior to donation of the cord blood. Within 48 hours after collection, mononuclear cells were isolated using ficoll (Lymphoprep, Fresenius Kabi Norge AS). CD34+ cells were isolated with double positive immunomagnetic selection using Magnetic Activated Cell Sorting (MACS) technology according instructions of the manufacturer (Miltenyi Biotech GmBH, Bergisch Gladbach, Germany). MACS-selected CD34+ cells were either used directly in experiments or stained with anti-Lin-FITC, anti-CD38-PerCP-Cy5.5, anti-CD90-PE (all from eBioscience, Vienna, Austria), anti-CD34-PE-Cy7, anti-CD45RA-APC-H7 (both from BD Biosciences, San Jose, CA, USA) and DAPI (Sigma-Aldrich, St Louis, MO, USA) after which viable DAPI-Lin-CD34+CD38lowCD45RAlowCD90+-cells, highly enriched for hematopoietic stem cells (HSC)[30 (link)], were sorted using BD FACSAria Cell Sorting System (BD Biosciences, San Jose, CA, USA).
+ Open protocol
+ Expand
3

Multimarker Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the isolation, characterization of MSCs was completed using anti-CD34 PE-Cy7 (BD Biosciences, San Diego, CA, USA), CD45 APC-Cy7 (BD Biosciences Pharmingen, San Diego, CA, USA), anti-CD73 PE (BD Biosciences Pharmingen), and anti-NG2 PE (Beckman Coulter, Marsellia, France) antibodies by flowcytometry (BD FACSCanto-II, USA) and DiVA software (BD Biosciences Pharmingen) (10 ,11 (link)).
+ Open protocol
+ Expand
4

Quantifying Cell Labeling Efficiency and Intensity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Labeling efficiency and median labeling intensity were determined using flow cytometry. Cells were stained with anti-CD45-APC-H7, anti-CD34-PE-Cy7 (both from BD Biosciences, San Jose, CA, USA) and diamidinophenylindole (DAPI) (Sigma-Aldrich, St Louis, MO, USA). Only viable (DAPI-) CD45+CD34+ cells were included in the analysis. The maximal fluorescence intensity of mock-labeled control cells in the FITC-channel was set as threshold for considering a cell labeled. Flow cytometric analysis was performed using a BD FACSCanto™ (BD Biosciences, San Jose, CA, USA) and data was analyzed using FlowJo software (Tree Star Inc, Ashland, OR, USA).
To assess 19F-PLGA labeling intensity in cells that divided 0–3 times, cells were labeled with 5μM CellTrace Violet (Molecular Probes, Eugene, Oregon, USA) upon 19F-PLGA labeling and subsequently cultured for 4 days in our culture medium as described above.
+ Open protocol
+ Expand
5

FACS Analysis of hESC-Derived Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
hMSCs derived from untransduced and transduced hESCs were resuspended in FACS buffer and stained with anti-CD105-APC antibodies (eBioscience, San Diego, CA) and analyzed by FACS. eGFP expression was measured in the CD105+ population. Similarly, hematopoietic cells derived from untransduced and transduced hESCs were resuspended in FACS buffer and stained with anti-CD34-PE-Cy7 (BD Biosciences) and anti-CD45-APC (Miltenyi Biotech, Bergish Gladbach, Germany) antibodies. Live cells identified by 7-AAD viability dye exclusion were analyzed for surface-marker and eGFP expression using a FACS Canto II. The populations analyzed were hemogenic progenitors (CD45CD34+), hematopoietic progenitors (CD45+CD34+), and mature blood cells (CD45+CD34).
+ Open protocol
+ Expand
6

Quantification of Human Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Absolute numbers of viable human CD34+ cells were determined by a single platform flow cytometric assay using anti‐FITC‐CD45, anti‐CD34‐PE, and Stem‐Count Fluorospheres from the Stem‐Kit Reagents kit (Beckman Coulter) and DAPI (Sigma). The frequencies of human phenotypic HSCs were determined using anti‐Lin‐FITC, anti‐CD38‐APC, anti‐CD90‐PE (Thermo Fisher Scientific), anti‐CD34‐PE‐Cy7, anti‐CD45RA‐APC‐H7 (BD Biosciences), and DAPI. All samples were analyzed using BD FACSCanto II (BD Biosciences), and the data were analyzed using FlowJo software (Tree Star, Inc, Ashland, OR, USA).
+ Open protocol
+ Expand
7

Quantifying Human Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Absolute numbers of viable human CD34+ cells were determined by a single platform flow cytometric assay using anti-FITC-CD45, anti-CD34-PE, and Stem-Count Fluorospheres - from the Stem-Kit Reagents kit (Beckman Coulter) and DAPI (Sigma). The frequencies of human phenotypic HSCs were determined using anti-Lin-FITC, anti-CD38-APC, anti-CD90-PE (Thermo Fisher Scientific), anti-CD34-PE-Cy7, anti-CD45RA-APC-H7 (BD Biosciences) and DAPI. All samples were analyzed using BD FACSCantoII (BD Biosciences), and the data was analyzed using FlowJo software (Tree Star, Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
8

Immunophenotyping of Hematopoietic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Annexin V-V450, anti-CD138-APC, anti-CD41a-PE, anti-P-gp-FITC, anti-CD34-PE-Cy7, matched isotype controls, BDTM CompBeads anti-mouse-Ig k, SpheroTM Rainbow calibration particles and TruCountTM tubes were from BD Biosciences (Sydney, NSW, Australia). Latex beads of 0.3 and 1.1 µm diameter were from Sigma-Aldrich (Sydney, NSW, Australia). Details of other reagents used are described in Supplementary Table 1.
+ Open protocol
+ Expand
9

Isolation and Identification of SVF Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SVF was isolated as described above and cells were directly subjected to immunofluorescence staining with anti-CD34-PE-Cy7 (BD Pharmingen, #556626), a rat monoclonal anti-human-DLK1/PREF1 antibody (Adipogen, AG-25A-0091) along with an anti-rat-APC antibody (BD Pharmingen, #551019) and anti-CD24-BV421 (Biolegend, #311121). Cells were sorted using a FACS Aria machine (BD, Bioscience, Vienna, Austria) and collected in ASC2 medium. Directly after sorting, cells were counted and immediately used for experiments.
+ Open protocol
+ Expand
10

Quantifying Endothelial Cells in Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM mononuclear cells (BMMNCs) were isolated with Ficoll-Paque solution (HaoYang, Tianjin, China). The following multicolour flow cytometry panel were applied to quantify ECs in BM: anti-CD34-PE/Cy7, anti-CD309-PE, and anti-CD133-APC (BD Biosciences, CA, USA). ECs were identified as CD34 + CD309 + CD133 + , and the relative EC frequency was expressed as a fraction of BMMNCs [23] [24] [25] [26] [27] . Samples were collected on a BD LSRFortessa flow cytometer and the compensation adjustion as well as data analysis were accomplished via a BD LSRFortessa software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!